Tumour model

OE19

Esophageal carcinoma
XenograftIn vitro

OE19 cells

Human OE19 cells were isolated from an adenocarcinoma of gastric cardia/oesophageal gastric junction of a patient.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID/CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing OE19 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1:(View PDF)
Tumour growth curve of the OE19 cells as subcutaneous tumors Mean ± SEM (n=3; take rate 100%)

Download PDF

Model characteristics

Organism
Human
Tissue of origin
Esophagus
Pathology
Esophageal carcinoma
Model type
In vitro, Xenograft
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Esophagus
XenograftIn vitro
Human
Esophagus
Carcinoma
XenograftIn vitro
Human
Esophagus
Esophageal squamous cell carcinoma
XenograftIn vitro
Human
Esophagus
Esophageal squamous cell carcinoma
XenograftIn vitro
Human
Esophagus
Squamous cell carcinoma
XenograftIn vitro
Human
Esophagus
Esophageal squamous cell carcinoma
XenograftIn vitro